Literature DB >> 26368281

Site-Selective Monitoring of the Interaction of the SRA Domain of UHRF1 with Target DNA Sequences Labeled with 2-Aminopurine.

Vanille J Greiner1, Lesia Kovalenko1,2, Nicolas Humbert1, Ludovic Richert1, Catherine Birck3, Marc Ruff3, Olga A Zaporozhets2, Sirano Dhe-Paganon4, Christian Bronner1,3, Yves Mély1.   

Abstract

UHRF1 plays a central role in the maintenance and transmission of epigenetic modifications by recruiting DNMT1 to hemimethylated CpG sites via its SET and RING-associated (SRA) domain, ensuring error-free duplication of methylation profiles. To characterize SRA-induced changes in the conformation and dynamics of a target 12 bp DNA duplex as a function of the methylation status, we labeled duplexes by the environment-sensitive probe 2-aminopurine (2-Ap) at various positions near or far from the central CpG recognition site containing either a nonmodified cytosine (NM duplex), a methylated cytosine (HM duplex), or methylated cytosines on both strands (BM duplex). Steady-state and time-resolved fluorescence indicated that binding of SRA induced modest conformational and dynamical changes in NM, HM, and BM duplexes, with only slight destabilization of base pairs, restriction of global duplex flexibility, and diminution of local nucleobase mobility. Moreover, significant restriction of the local motion of residues flanking the methylcytosine in the HM duplex suggested that these residues are more rigidly bound to SRA, in line with a slightly higher affinity of the HM duplex as compared to that of the NM or BM duplex. Our results are consistent with a "reader" role, in which the SRA domain scans DNA sequences for hemimethylated CpG sites without perturbation of the structure of contacted nucleotides.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26368281     DOI: 10.1021/acs.biochem.5b00419

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Dynamics of Methylated Cytosine Flipping by UHRF1.

Authors:  Vasyl Kilin; Krishna Gavvala; Nicolas P F Barthes; Benoît Y Michel; Dongwon Shin; Christian Boudier; Olivier Mauffret; Valeriy Yashchuk; Marc Mousli; Marc Ruff; Florence Granger; Sylvia Eiler; Christian Bronner; Yitzhak Tor; Alain Burger; Yves Mély
Journal:  J Am Chem Soc       Date:  2017-02-02       Impact factor: 15.419

2.  Base-Stacking Heterogeneity in RNA Resolved by Fluorescence-Detected Circular Dichroism Spectroscopy.

Authors:  Julia R Widom; Janson E Hoeher
Journal:  J Phys Chem Lett       Date:  2022-08-19       Impact factor: 6.888

Review 3.  The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.

Authors:  Christian Bronner; Marc Mousli; Waseem Ashraf; Abdulkhaleg Ibrahim; Mahmoud Alhosin; Liliyana Zaayter; Khalid Ouararhni; Christophe Papin; Tanveer Ahmad; Ali Hamiche; Yves Mély
Journal:  Oncotarget       Date:  2017-04-24

Review 4.  Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.

Authors:  Debasis Patnaik; Pierre-Olivier Estève; Sriharsa Pradhan
Journal:  Oncotarget       Date:  2018-05-25

Review 5.  Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns.

Authors:  Christian Bronner; Mahmoud Alhosin; Ali Hamiche; Marc Mousli
Journal:  Genes (Basel)       Date:  2019-01-18       Impact factor: 4.096

6.  Systematic analysis of the binding behaviour of UHRF1 towards different methyl- and carboxylcytosine modification patterns at CpG dyads.

Authors:  Markus Schneider; Carina Trummer; Andreas Stengl; Peng Zhang; Aleksandra Szwagierczak; M Cristina Cardoso; Heinrich Leonhardt; Christina Bauer; Iris Antes
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.